Kong L - Search Results

1

Dickkopf 1 impairs the tumor response to PD-1 blockade by inactivating CD8+ T cells in deficient mismatch repair colorectal cancer.

Sui Q, Liu D, Jiang W, Tang J, Kong L, Han K, Liao L, Li Y, Ou Q, Xiao B, Liu G, Ling Y, Chen J, Liu Z, Zuo Z, Pan Z, Zhou P, Zheng J, Ding PR. Sui Q, et al. Among authors: kong l. J Immunother Cancer. 2021 Mar;9(3):e001498. doi: 10.1136/jitc-2020-001498. J Immunother Cancer. 2021. PMID: 33782107 Free PMC article.

2

[Surgical treatment for gastrointestinal stromal tumor].

Wan DS, Wu XJ, Ding PR, Pan ZZ, Zhou ZW, Chen G, Li LR, Lu ZH, Kong LH, Liang XM, Luo RZ. Wan DS, et al. Zhonghua Wai Ke Za Zhi. 2007 Aug 1;45(15):1037-40. Zhonghua Wai Ke Za Zhi. 2007. PMID: 18005584 Chinese.

3

[Prognosis of rectal cancer patients after total mesorectal excision].

Pan ZZ, Ding PR, Wan DS, Li LR, Wu XJ, Lu ZH, Kong LH, Lin JZ, Zhou ZG. Pan ZZ, et al. Ai Zheng. 2009 Sep;28(9):903-7. doi: 10.5732/cjc.008.10804. Ai Zheng. 2009. PMID: 19728904 Free article. Chinese.

4

Zeng ZF, Ding PR, Pan ZZ, Lin JZ, Li LR, Lu ZH, Wu XJ, Kong LH, Zhou ZG, Wan DS. Zeng ZF, et al. Ai Zheng. 2009 Sep;28(9):923-7. doi: 10.5732/cjc.008.10806. Ai Zheng. 2009. PMID: 19728908 Free article. Chinese.

5

[Relationship between body mass index and colon cancer].

Zheng MC, Kong LH, Lu ZH, Fang YJ, Pan ZZ, Zhu YP, Wen YS, Wan DS. Zheng MC, et al. Ai Zheng. 2009 Sep;28(9):928-31. doi: 10.5732/cjc.009.10080. Ai Zheng. 2009. PMID: 19728909 Free article. Chinese.

6

[Surgical treatment for 140 patients with gastric stromal tumors].

Wu XJ, Fang YJ, Lu ZH, Lin JZ, Wan DS, Ding PR, Chen G, Li LR, Kong LH, Pan ZZ. Wu XJ, et al. Zhonghua Wei Chang Wai Ke Za Zhi. 2010 Jun;13(6):417-20. Zhonghua Wei Chang Wai Ke Za Zhi. 2010. PMID: 20577918 Chinese.

7

Elevated preoperative neutrophil to lymphocyte ratio predicts risk of recurrence following curative resection for stage IIA colon cancer.

Ding PR, An X, Zhang RX, Fang YJ, Li LR, Chen G, Wu XJ, Lu ZH, Lin JZ, Kong LH, Wan DS, Pan ZZ. Ding PR, et al. Int J Colorectal Dis. 2010 Dec;25(12):1427-33. doi: 10.1007/s00384-010-1052-0. Epub 2010 Sep 7. Int J Colorectal Dis. 2010. PMID: 20821217

8

Expression of COX-2, MMP-2 and VEGF in stage II and III colorectal cancer and the clinical significance.

Peng ZH, Wan DS, Li LR, Chen G, Lu ZH, Wu XJ, Kong LH, Pan ZZ. Peng ZH, et al. Hepatogastroenterology. 2011 Mar-Apr;58(106):369-76. Hepatogastroenterology. 2011. PMID: 21661398

9

Celecoxib can prevent capecitabine-related hand-foot syndrome in stage II and III colorectal cancer patients: result of a single-center, prospective randomized phase III trial.

Zhang RX, Wu XJ, Wan DS, Lu ZH, Kong LH, Pan ZZ, Chen G. Zhang RX, et al. Among authors: kong lh. Ann Oncol. 2012 May;23(5):1348-1353. doi: 10.1093/annonc/mdr400. Epub 2011 Sep 22. Ann Oncol. 2012. PMID: 21940785 Free article. Clinical Trial.

10

Neuroprotective effect of neurotropin on chronic oxaliplatin-induced neurotoxicity in stage II and stage III colorectal cancer patients: results from a prospective, randomised, single-centre, pilot clinical trial.

Zhang RX, Lu ZH, Wan DS, Wu XJ, Ding PR, Kong LH, Pan ZZ, Chen G. Zhang RX, et al. Among authors: kong lh. Int J Colorectal Dis. 2012 Dec;27(12):1645-50. doi: 10.1007/s00384-012-1509-4. Epub 2012 Jun 5. Int J Colorectal Dis. 2012. PMID: 22664945 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,306 results

Search Page

Filters